5 research outputs found
Reproduction, larviculture and early development of the Bluebanded goby, Lythrypnus dalli, an emerging model organism for studies in evolutionary developmental biology and sexual plasticity
The Bluebanded goby, Lythrypnus dalli, is a popular ornamental aquarium species and a key organism for the study of several fundamental biological questions, most notably reversible sex change in adults. To maximize the tractability of this species as an emerging model system, it is essential to have an optimized propagation system and a detailed developmental staging scheme. One limitation to the larviculture of L. dalli is the relatively small size of the larvae, which makes the transition from yolk to feeding challenging. We developed a protocol and successfully reared three generations of L. dalli in the laboratory. The protocol contains several key innovations for the rearing of diminutive fish larvae, including tank design and co-culturing of microalgae (Isochrysis galbana) with copepods (Parvocalanus sp.) in the larval rearing tanks. In addition, we describe the embryonic and larval development of L. dalli under controlled conditions and in comparison with the model organism Danio rerio. We found that at 21°C L. dalli larvae hatch in 4 days, reach flexion in 18-25 days and are sexually mature by 3 months. Overall, the embryonic development of L. dalli is remarkably similar to D. rerio with several striking differences, including the position and shape of the blastomere, size of the neuromasts and corresponding cupula, and relative timing of pigmentation and brain subdivision. The ability to rear this species in captivity is a valuable tool that could be utilized for a variety of similarly diminutive species and to address a greater breadth and depth of biological questions
Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia
Juvenile myelomonocytic leukemia is an
aggressive and frequently lethal myeloproliferative disorder of childhood. Somatic mutations in NRAS, KRAS, or
PTPN11 occur in 60% of cases. Monitoring disease status is difficult because of
the lack of characteristic leukemic blasts
at diagnosis. We designed a fluorescently
based, allele-specific polymerase chain
reaction assay called TaqMAMA to detect
the most common RAS or PTPN11 mutations. We analyzed peripheral blood
and/or bone marrow of 25 patients for
levels of mutant alleles over time. Analysis of pre–hematopoietic stem-cell transplantation, samples revealed a broad distribution of the quantity of the mutant
alleles. After hematopoietic stem-cell
transplantation, the level of the mutant
allele rose rapidly in patients who relapsed and correlated well with falling
donor chimerism. Simultaneously analyzed peripheral blood and bone marrow
samples demonstrate that blood can be
monitored for residual disease. Importantly, these assays provide a sensitive
strategy to evaluate molecular responses
to new therapeutic strategies
Recommended from our members
Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia.
CBL encodes a member of the Cbl family of proteins, which functions as an E3 ubiquitin ligase. We describe a dominant developmental disorder resulting from germline missense CBL mutations, which is characterized by impaired growth, developmental delay, cryptorchidism and a predisposition to juvenile myelomonocytic leukemia (JMML). Some individuals experienced spontaneous regression of their JMML but developed vasculitis later in life. Importantly, JMML specimens from affected children show loss of the normal CBL allele through acquired isodisomy. Consistent with these genetic data, the common p.371Y>H altered Cbl protein induces cytokine-independent growth and constitutive phosphorylation of ERK, AKT and S6 only in hematopoietic cells in which normal Cbl expression is reduced by RNA interference. We conclude that germline CBL mutations have developmental, tumorigenic and functional consequences that resemble disorders that are caused by hyperactive Ras/Raf/MEK/ERK signaling and include neurofibromatosis type 1, Noonan syndrome, Costello syndrome, cardiofaciocutaneous syndrome and Legius syndrome
Mutations in CBL occur frequently in juvenile myelomonocytic leukemia
Juvenile myelomonocytic leukemia is an aggressive myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Seventy-five percent of patients harbor mutations in the NF1, NRAS, KRAS, or PTPN11 genes, which encode components of Ras signaling networks. Using single nucleotide polymorphism arrays, we identified a region of 11q isodisomy that contains the CBL gene in several JMML samples, and subsequently identified CBL mutations in 27 of 159 JMML samples. Thirteen of these mutations alter codon Y371. In this report, we also demonstrate that CBL and RAS/PTPN11 mutations were mutually exclusive in these patients. Moreover, the exclusivity of CBL mutations with respect to other Ras pathway-associated mutations indicates that CBL may have a role in deregulating this key pathway in JMML
Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia
CBL encodes a member of the Cbl family of proteins, which functions as an E3 ubiquitin ligase. We describe a dominant developmental disorder resulting from germline missense CBL mutations, which is characterized by impaired growth, developmental delay, cryptorchidism and a predisposition to juvenile myelomonocytic leukemia (JMML). Some individuals experienced spontaneous regression of their JMML but developed vasculitis later in life. Importantly, JMML specimens from affected children show loss of the normal CBL allele through acquired isodisomy. Consistent with these genetic data, the common p.371Y>H altered Cbl protein induces cytokine-independent growth and constitutive phosphorylation of ERK, AKT and S6 only in hematopoietic cells in which normal Cbl expression is reduced by RNA interference. We conclude that germline CBL mutations have developmental, tumorigenic and functional consequences that resemble disorders that are caused by hyperactive Ras/Raf/MEK/ERK signaling and include neurofibromatosis type 1, Noonan syndrome, Costello syndrome, cardiofaciocutaneous syndrome and Legius syndrome